MHR
SEM

Matthew Hamilton Rosenberg’s Select Medical SEM Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4
Closed -$47 – 912
2023
Q4 		$47 Hold
4
– – ﹤0.01% 902
2023
Q3 		$51 Hold
4
– – ﹤0.01% 912
2023
Q2 		$64 Buy
+4
New +$62 ﹤0.01% 929

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Matthew Hamilton Rosenberg's SEM Position: Q1 2024 in Review

Matthew Hamilton Rosenberg sold out of Select Medical (SEM) in Q1 2024, closing a stake of 4 shares — an estimated $47 sold.

Matthew Hamilton Rosenberg first reported a position in SEM in Q2 2023 and held it in 3 quarters. The position peaked at $64 in Q2 2023. 250 funds tracked by Wall St. Rank hold SEM as of Q1 2024.

  • Matthew Hamilton Rosenberg reported no remaining Select Medical position as of Q1 2024 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 4 Select Medical shares in Q1 2024, an estimated $47.
  • Matthew Hamilton Rosenberg first reported a position in Select Medical in Q2 2023 and held it in 3 quarters.
  • Matthew Hamilton Rosenberg's Select Medical position peaked at $64 in Q2 2023.
  • 250 funds tracked by Wall St. Rank held Select Medical as of Q1 2024.

Based on Matthew Hamilton Rosenberg's 13F filing for Q1 2024, filed 22 Apr 2024.